Loading organizations...
Loading organizations...
CDMO specializing in Cell and Gene Therapy with end-to-end services.
Porton Advanced Solutions has raised $80.0M across 1 funding round.
Porton Advanced Solutions has raised $80.0M in total across 1 funding round.
Porton Advanced Solutions has raised $80.0M in total across 1 funding round.
Porton Advanced Solutions's investors include China Merchants Capital, Merchant Health, CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, SDICTK.
Porton Advanced Solutions has raised $80.0M across 1 funding round. Most recently, it raised $80.0M Series B in August 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 22, 2022 | $80.0M Series B | China Merchants Capital, Merchant Health | CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Ventures, Porton Pharma Solutions, Ruilian Xingshan Capital, SDICTK |